Navigation Links
Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint

y not warrant further development of this compound for the treatment of chronic hepatitis B and completing our clinical studies may take longer or cost more than expected. In addition, feedback from regulatory authorities or results from clinical trials might require modifications or delays in later stage clinical trials or additional trials to be performed. Further, the FDA and other regulatory authorities may not approve tenofovir DF for the treatment of chronic hepatitis B, and marketing approval, if granted, may have significant limitations on its use and physicians and may not see advantages of tenofovir DF over other treatment options and may therefore be reluctant to prescribe tenofovir DF for chronic hepatitis B. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead's Annual Report on Form 10-K for the year ended December 31, 2006 and its Quarterly Report on Form 10-Q for the first quarter of 2007, filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.

Hepsera and Viread are registered trademarks of Gilead Sciences, Inc.

For more information on Gilead, please call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235) or visit www.gilead.com.


CONTACT: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investors)
James Loduca, 650-522-5908 (Media)
www.gilead.com

SOURCE: Gilead Sciences, Inc.



'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
4. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
5. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
6. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
9. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
10. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
Post Your Comments:
(Date:11/27/2014)... -- - New Solution That Makes JINS ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC PACK" in ... or $5,000 (without tax /including two pairs of JINS MEME ... dedicated solution of "JINS MEME" to academic researchers, and it ... by electrooculography and six-axis sensors without API. (*Physiological data that ...
(Date:11/26/2014)... 26, 2014  Thoratec Corporation (NASDAQ: THOR ... therapies to save, support and restore failing hearts, said ... conferences. On Tuesday, December 2, the company ... Jaffray Healthcare Conference.  D. Keith Grossman , President ... the company beginning at 11:30 a.m., Eastern Standard Time ...
(Date:11/26/2014)...   Royal Philips (NYSE: ... of its portfolio of diagnostic X-ray solutions ... , ProGrade and PrimaryDiagnost[ii]. With new releases of ... U.S., and availability of all these solutions in ... innovative solutions designed to meet the needs and ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Thoratec Announces Presentations At Investor Conferences For December 2014 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3
(Date:11/27/2014)... (PRWEB) November 27, 2014 In order to ... from Sharpes, Fla., designed an easy way to avoid touching ... , He then created a prototype of the patent-pending Toilet ... lower a toilet seat and/or lid in a more sanitary ... the spread of germs. Overall, it promotes good hygiene and ...
(Date:11/27/2014)... November 27, 2014 The founders of VIM ... comfortable and high functioning compression socks, are proud to announce ... use an innovative Gradient Pressure (TM) knitting technology that is ... VIM & VIGR’s commitment to adding flair and style to ... functional recently caught the eye of a writer at ...
(Date:11/27/2014)... Jeffrey Carlini has practiced public ... area providing audits, reviews, compilations, tax preparation, business ... varying size across numerous industries. Jeff has worked ... of their accounting and tax needs. , Jeff ... Program. When asking Mr. Carlini about his recent ...
(Date:11/27/2014)... Vegas, NV (PRWEB) November 27, 2014 ... 2014 shopping season has officially launched, Emassagechair.com ... and Cyber Monday Discount Event. , Negotiating on ... relationships with top massage chair brands, Emassagechair.com has generated ... their best deals and biggest discounts yet. , Shoppers ...
(Date:11/27/2014)... York, New York (PRWEB) November 27, 2014 ... of individuals who were allegedly injured by the medication ... where a federal litigation is looking ahead to a ... , According to a Scheduling Order issued earlier this ... place on December 16th at 10:00 a.m. Items likely ...
Breaking Medicine News(10 mins):Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3
... type 1 a rare disease in which tumors grow ... by crosstalk between cells in the nerves and cells in ... National Institutes of Health (NIH) and the Department of Defense ... treating certain kinds of blood cancer curbs tumor growth in ...
... One errant cough or unexpected,sneeze and the workplace ... As the flu season approaches, HR managers prepare to,deal ... estimates that the cost of influenza to the U.S. ... can range from $71 billion,to $167 billion a year., ...
... Living,Inc. (NYSE: SRZ ) today announced that it ... 7, 2008, at 9:00 a.m. ET to discuss the,financial ... executive,officer (effective November 1, 2008), Richard Nadeau, chief financial,officer, ... call., The call-in number for the conference call ...
... Institute of Health and Nutrition, Latino Nutrition Coalition are ... ... Inc. (GMI), today,announced the launch of a unique, three-year, grassroots program ... nutritious food as part of their daily routine. Called Mente,Sana en ...
... Action Network, American,Heart Association, American Lung Association, American ... Oct. 30 Demonstrating again that,it is not ... Philip Morris,is launching an aggressive new campaign to ... campaign is built around a new look for ...
... LLC formally launched a,refreshed website ( ... and,potential customers on October 28, 2008. The ... target-market, including temporary,nurse staffing agencies, medical transcription ... healthcare vendors., Some of the site,s ...
Cached Medicine News:Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 2Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 3Health News:Going 'Green' May Mean Fewer Colds This Season 2Health News:Going 'Green' May Mean Fewer Colds This Season 3Health News:Sunrise to Host Conference Call and Webcast to Discuss the Company's Financial Results for the Third Quarter 2008 2Health News:General Mills, Inc. Launches One-Of-A-Kind Grassroots Health and Nutrition Initiative Designed to Help Hispanic Families Eat Better 2Health News:General Mills, Inc. Launches One-Of-A-Kind Grassroots Health and Nutrition Initiative Designed to Help Hispanic Families Eat Better 3Health News:Deadly in Pink: Philip Morris' New Look for Virginia Slims Cigarettes Shows Contempt for Women's Health 2Health News:Deadly in Pink: Philip Morris' New Look for Virginia Slims Cigarettes Shows Contempt for Women's Health 3Health News:PRN Funding Refreshes Website Experience 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: